Page 22 - Read Online

Page 16 Bax. J Transl Genet Genom 2020;4:1-16 I http://dx.doi.org/10.20517/2020.08

encephalomyopathy-like syndrome after allogeneic haematopoietic stem cell transplantation. BMJ Case Rep 2017;2017.
102. Sicurelli F, Carluccio MA, Toraldo F, Tozzi M, Bucalossi A, et al. Clinical and biochemical improvement following HSCT in a patient
with MNGIE: 1-year follow-up. J Neurol 2012;259:1985-7.
103. Naymagon S, Naymagon L, Wong SY, Ko HM, Renteria A, et al. Acute graft-versus-host disease of the gut: considerations for the
gastroenterologist. Nat Rev Gastroenterol Hepatol 2017;14:711-26.
104. D’Angelo R, Rinaldi R, Pironi L, Dotti MT, Pinna AD, et al. Liver transplant reverses biochemical imbalance in mitochondrial
neurogastrointestinal encephalomyopathy. Mitochondrion 2017;34:101-2.
105. Boschetti E, D’Alessandro R, Bianco F, Carelli V, Cenacchi G, et al. Liver as a source for thymidine phosphorylase replacement in
mitochondrial neurogastrointestinal encephalomyopathy. PLoS One 2014;9:e96692.
106. Madhok J, Leong J, Cohn J. Anesthetic considerations for liver transplantation in a patient with mitochondrial neurogastrointestinal
encephalopathy syndrome. Cureus 2019;11:e5038.
107. De Vocht C, Ranquin A, Willaert R, Van Ginderachter JA, Vanhaecke T, et al. Assessment of stability, toxicity and immunogenicity of
new polymeric nanoreactors for use in enzyme replacement therapy of MNGIE. J Control Release 2009;137:246-54.
108. López LC, Akman HO, García-Cazorla A, Dorado B, Martí R, et al. Unbalanced deoxynucleotide pools cause mitochondrial DNA
instability in thymidine phosphorylase-deficient mice. 2009;18:714-22.
109. Torres-Torronteras J, Gómez A, Eixarch H, Palenzuela L, Pizzorno G, et al. Hematopoietic gene therapy restores thymidine phosphorylase
activity in a cell culture and a murine model of MNGIE. Gene Ther 2011;18:795-806.
110. Torres-Torronteras J, Cabrera-Pérez R, Barba I, Costa C, de Luna N, et al. Long-term restoration of thymidine phosphorylase function and
nucleoside homeostasis using hematopoietic gene therapy in a murine model of mitochondrial neurogastrointestinal encephalomyopathy.
Hum Gene Ther 2016;27:656-67.
111. Yadak R, Boot M V., Van Til NP, Cazals-Hatem D, Finkenstedt A, et al. Transplantation, gene therapy and intestinal pathology in MNGIE
patients and mice. BMC Gastroenterol 2018;18:149.
112. Torres-Torronteras J, Viscomi C, Cabrera-Pérez R, Cámara Y, Di Meo I, et al. Gene therapy using a liver-targeted AAV vector restores
nucleoside and nucleotide homeostasis in a murine model of MNGIE. Mol Ther 2014;22:901-7.
113. Torres-Torronteras J, Cabrera-Pérez R, Vila-Julià F, Viscomi C, Cámara Y, et al. Long-term sustained effect of liver-targeted adeno-
associated virus gene therapy for mitochondrial neurogastrointestinal encephalomyopathy. Hum Gene Ther 2018;29:708-18.